Participants with obesity at baseline also had less reduction in swollen and tender joint counts, CRP and assessment scores of disease activity and pain after treatment initiation compared with the rest of the cohort (figure 3B). This evidence concerns the gene CRP and obesity due to melanocortin 4 receptor deficiency.